Preliminary findings of a phase I dose-escalation study of sunitinib in combination with gemcitabine plus cisplatin in advanced non-small cell lung cancer (NSCLC)

被引：0
作者：
Reck, M. [1 ]
Frickhofen, N. [2 ]
Gatzemeier, U. [1 ]
Fuhr, H. G. [2 ]
Lanzalone, S. [3 ]
Wang, E. [4 ]
Chao, R. [4 ]
Felip, E. [5 ]
机构：
[1] Hosp Grosshansdorf, Dept Thorac Oncol, Grosshansdorf, Germany
[2] Dr Horst Schmidt Klin, Wiesbaden, Germany
[3] Pfizer Italia, Milan, Italy
[4] Pfizer Inc, Global Res & Dev, La Jolla, CA USA
[5] Vall Hebron Univ Hosp, Dept Oncol, Barcelona, Spain
来源：
EJC SUPPLEMENTS | 2007年 / 5卷 / 04期
关键词：
D O I：
10.1016/S1359-6349(07)71435-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6607
引用
收藏
页码：390 / 390
页数：1
相关论文
共 50 条
[41]   Vinorelbine/gemcitabine in advanced non-small cell lung cancer (NSCLC):: a phase I trial [J].
Krajnik, G ;
Wein, W ;
Greil, R ;
Marhold, F ;
Mohn-Staudner, A ;
Kummer, F ;
Malayeri, R ;
Zöchbauer-Müller, S ;
Huber, H ;
Pirker, R .
EUROPEAN JOURNAL OF CANCER, 1998, 34 (12) :1977-1980
[42]   Combination of gemcitabine and cisplatin for advanced non-small cell lung cancer: a phase II study with emphasis on scheduling [J].
Huisman, C ;
Giaccone, G ;
van Groeningen, CJ ;
Sutedja, G ;
Postmus, PE ;
Smit, EF .
LUNG CANCER, 2001, 33 (2-3) :267-275
[43]   Phase I trial of gemcitabine (GEM) and cisplatin (CP) for non-small cell lung cancer (NSCLC) [J].
Shepherd, F ;
Cormier, Y ;
Burges, R ;
Crump, M ;
Strack, T .
EUROPEAN JOURNAL OF CANCER, 1995, 31A :1080-1080
[44]   Phase I study of low-dose cisplatin (CDDP) and gemcitabine (GEM) chemotherapy for elderly patients with advanced non-small cell lung cancer (NSCLC) [J].
Buffoni, L. ;
Dongiovanni, D. ;
Barone, C. ;
Fissore, C. ;
Larovere, E. ;
Grillo, R. ;
Salvadori, A. ;
Birocco, N. ;
Ciuffreda, L. ;
Bertetto, O. ;
Schena, M. .
ANNALS OF ONCOLOGY, 2006, 17 :XI21-XI22
[45]   Phase I dose escalation study of amrubicin plus paclitaxel in previously treated advanced non-small cell lung cancer [J].
Kaira, Kyoichi ;
Sunaga, Noriaki ;
Imai, Hisao ;
Kamide, Yosuke ;
Koga, Yasuhiko ;
Ono, Akihiro ;
Kuwako, Tomohito ;
Masuda, Tomomi ;
Hisada, Takeshi ;
Ishizuka, Tamotsu ;
Yamada, Masanobu .
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2016, 21 (02) :240-247
[46]   Study of paclitaxel and dose escalation of cisplatin in patients with advanced non-small cell lung cancer [J].
Watanabe, H ;
Yamamoto, N ;
Tamura, T ;
Shimoyama, T ;
Hotta, K ;
Inoue, A ;
Sawada, M ;
Akiyama, Y ;
Kusaba, H ;
Nokihara, H ;
Sekine, I ;
Kunitoh, H ;
Ohe, Y ;
Kodama, T ;
Saijo, N .
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2003, 33 (12) :626-630
[47]   Phase I dose escalation study of amrubicin plus paclitaxel in previously treated advanced non-small cell lung cancer [J].
Kyoichi Kaira ;
Noriaki Sunaga ;
Hisao Imai ;
Yosuke Kamide ;
Yasuhiko Koga ;
Akihiro Ono ;
Tomohito Kuwako ;
Tomomi Masuda ;
Takeshi Hisada ;
Tamotsu Ishizuka ;
Masanobu Yamada .
International Journal of Clinical Oncology, 2016, 21 :240-247
[48]   Phase II study of Gemcitabine, ifosfamide and cisplatin (GIP) in patients with advanced non-small cell lung cancer (NSCLC) [J].
De las Penas, R ;
Busquier, I ;
Munarriz, J ;
Lopez, A ;
Llorente, R ;
Alberola, V ;
Frau, A .
ANNALS OF ONCOLOGY, 1998, 9 :88-88
[49]   Gemcitabine and cisplatin in advanced non small cell lung cancer (NSCLC) [J].
Garcia-Gomez, R ;
Lopez-Criado, P ;
Guevara, S ;
Lahoz, C ;
Chaib, C ;
Gonzalez, C ;
Santiago, J ;
De Alvaro, J ;
Carrion, R ;
Perez-Manga, G .
ANNALS OF ONCOLOGY, 1998, 9 :93-94
[50]   Phase I study of gemcitabine (GEM) and carboplatin (CBDCA) in advanced non-small cell lung cancer (NSCLC). [J].
Kawabata, S ;
Oka, M ;
Fukuda, M ;
Kinoshita, A ;
Fukuda, M ;
Nagashima, S ;
Nakamura, Y ;
Nakano, H ;
Soda, H ;
Kohno, S .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) :688S-688S
12345